Search clinical trials for: BI 695501 prefilled syringe

Total 395 results

University Medical Centre Ljubljana

Enrolling by invitation

Osteoporosis in Primary Hyperparathyroidism

Primary Hyperparathyroidism | Osteoporosis

Slovenia
Hamad Medical Corporation

Terminated

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis (DOHA)

Osteoporosis | Thalassemia Majors (Beta-Thalassemia Major)

Qatar
Marinus Pharmaceuticals

Completed

Open-label Extension to Protocol 1042-0600

Epilepsies, Partial

United States
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma

Lymphoma, Follicular

Spain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
University of Valencia
Regedent AG, Zürich

Unknown

Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.

Chronic Periodontitis | Periodontal Bone Loss
Centre hospitalier de l'Université de Montréal...

Active, not recruiting

Dupilumab for Prevention of Recurrence of CRSwNP After ESS

Chronic Rhinosinusitis With Nasal Polyps

Canada
Turku University Hospital
Amgen

Completed

Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women (ProliaHip)

Hip Osteoarthritis

Finland
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Healthy

Germany
Eli Lilly and Company

Terminated

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Argentina, United States, Czechia, Puerto Rico, Russian Federation, Poland
Stanford University

Recruiting

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Venous Thromboembolism

United States
Children's Hospital Zagreb
GuardianMed j.d.o.o. Research and development in medicine

Withdrawn

Antiseptic-coated Intermittent Urinary Catheter (GuardianCath)

Catheter-Related Infections | Neurogenic Bladder

Croatia
Boehringer Ingelheim

Terminated

Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

United States, United Kingdom, Netherlands, Ireland, Argentina, Poland, Mexico, Spain, Bulgaria, Chile, Germany, Ukraine, Portugal, Belgium, Canada, Greece, Hungary
Centre Hospitalier Universitaire de Saint Etienne
CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang

Withdrawn

Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention (COV-ENOX)

Sars-CoV2

France
Boehringer Ingelheim

Completed

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Carcinoma, Non-Small-Cell Lung

Spain, Bulgaria, Serbia, United Kingdom, United States, Korea, Republic of, Malaysia, Vietnam, Poland, Egypt, Hungary, Ukraine, Brazil, Turkey, Japan, Portugal, Thailand, Philippines, Russian Federation, Italy, Mexico, Greece, Croatia, Chi... and more
Movetis

Completed

Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation

Constipation
Boehringer Ingelheim

Completed

Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer (INVICTAN®-3)

Colorectal Neoplasms

United States, Spain, Ukraine, Japan
Boehringer Ingelheim

Completed

Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects

Healthy

New Zealand
Indonesia University
PT Metiska Farma

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin

Indonesia
medac GmbH

Completed

Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Germany
Merck Sharp & Dohme LLC

Completed

Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) (SMART)

Ulcerative Colitis
University of Leeds

Recruiting

Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis (ARCADIA)

Inflammatory Arthritis

United Kingdom
University of Aarhus
Aarhus University Hospital

Recruiting

Thromboprophylaxis in Oesophageal Cancer Patients (TOP-RCT)

Thrombosis | Esophageal Neoplasms | Thromboembolism

Denmark
Cinnagen

Completed

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis (RRMS)

Iran, Islamic Republic of
SIGA Technologies
United States Department of Defense

Completed

Study to Assess the Safety and Pharmacokinetics of TPOXX® When Administered Orally for 28 Days

Smallpox

United States
Institute of Cell Therapy
The Institute of Traumatology and Orthopedics of NAMS of Ukraine; Kyiv City...

Unknown

Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis

Knee Osteoarthritis

Ukraine
David Jang, M.D.
Amgen

Completed

Erenumab for Idiosyncratic Facial Pain

Facial Pain | Rhinosinusitis

United States
University of California, San Francisco
Eli Lilly and Company

Recruiting

Galcanezumab for Vestibular Migraine

Vestibular Migraine

United States
Boehringer Ingelheim

Terminated

A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Liver Diseases | Hypertension, Portal

Spain, Denmark, Singapore, Germany, Italy, Austria, Canada, Netherlands, China, Israel, Belgium, United States, Japan, Argentina, France, Romania
Eli Lilly and Company

Completed

A Study of Mirikizumab in Healthy Participants

Healthy

United States
Eli Lilly and Company

Completed

A Study of Two Formulations of LY3074828 in Healthy Participants

Healthy

United States
Goethe University

Active, not recruiting

Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients (ACO/ARO/AIO-21)

Rectal Cancer

Germany
University of Liege
Université Catholique de Louvain

Active, not recruiting

Treating Severe Brain-injured Patients With Apomorphine

Disorder of Consciousness

Belgium
Universitaire Ziekenhuizen KU Leuven
Ziekenhuis Netwerk Antwerpen (ZNA)

Completed

Abatacept in Patients With Birdshot HLA A29 Uveitis (HLA-A29)

Eye Diseases | Uveitis

Belgium
Beth Israel Deaconess Medical Center
Eli Lilly and Company

Active, not recruiting

Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action

Chronic Migraine

United States
University of Maryland, Baltimore
Amgen

Terminated

Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) (TMD CARE)

Temporomandibular Disorders

United States
Eli Lilly and Company

Completed

A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants

Healthy

United States
Sarah Sabry Hashem

Completed

Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

Mitral Valve Disease

Egypt
Pfizer

Completed

Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Rheumatoid Arthritis

France, Germany, Italy, Sweden, United Kingdom, Netherlands, Denmark, Finland, Norway
University of Washington
National Cancer Institute (NCI)

Terminated

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Recurrent Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Waldenstrom Macroglobulinemia | Refractory Waldenstrom Macroglobulinemia

United States
National Cancer Institute (NCI)

Completed

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditions

United States
National Cancer Institute (NCI)

Completed

Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia

United States
Boehringer Ingelheim

Completed

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran Etexilate

Healthy

Belgium
Luye Pharma Group Ltd.

Completed

A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients

Schizophrenia | Schizoaffective Disorder | Schizo Affective Disorder

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditions

United States
Royal Marsden NHS Foundation Trust
Pfizer; Breast Cancer Now

Active, not recruiting

Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours (ROLo)

Gastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene Mutation

United Kingdom
Tongji Hospital
Wuhan Central Hospital; Wuhan Hospital of Traditional Chinese Medicine

Recruiting

A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)

Pemphigus Vulgaris

China
Assiut University

Unknown

Pain Relief During IUD Insertion in Women Delivered Only by Elective Cesarean Section

IUD Insertion Complication
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

Drug-drug Interaction (DDI) With a P-gp Inhibitor, Organic Anion Transporting Polypeptide OATP-inhibitor, Food Effect

Healthy

Germany
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Recurrent Indolent Adult Non-Hodgkin Lymphoma

United States

Search clinical trials for: BI 695501 prefilled syringe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations